Antivirals
Antivirals are compounds specifically designed to inhibit the replication and spread of viruses, playing a critical role in the treatment and prevention of viral infections. In this category, you will find a comprehensive selection of antiviral agents intended for laboratory research purposes only. These products are essential for studying viral mechanisms, developing new antiviral therapies, and understanding resistance patterns. Researchers can utilize these antivirals to investigate the efficacy and safety of potential treatments, contributing to the advancement of medical science and the development of innovative antiviral drugs. The availability of diverse antiviral agents supports cutting-edge research in virology and enhances our ability to combat viral diseases.
Found 762 products of "Antivirals"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
8-epiAtazanavir
CAS:<p>8-epiAtazanavir is a stereoisomer of the antiretroviral drug Atazanavir, which is derived from synthetic sources. It acts as an HIV-1 protease inhibitor, where it binds to the active site of the viral protease enzyme, thereby preventing the cleavage of precursor proteins required for the maturation of infectious viral particles. This interference with viral replication is achieved by the structural mimicry of the natural substrate of the protease, allowing it to competitively inhibit the enzyme's activity.</p>Formula:C38H52N6O7Purity:Min. 95%Molecular weight:704.38975Carbovir triphosphate triethylamine
CAS:<p>Carbovir triphosphate triethylamine is a nucleotide analog, which is a derivative of nucleoside analogs designed for antiviral applications. It is synthesized through chemical modification of guanosine analogs, resulting in its active triphosphate form. This compound functions as a potent antiretroviral agent by mimicking natural nucleotides and interfering with viral DNA synthesis. The active triphosphate impedes the action of viral reverse transcriptase by incorporating itself into the viral DNA chain, causing premature termination and effectively halting viral replication.</p>Purity:Min. 95%Paritaprevir
CAS:<p>Paritaprevir is an antiviral medication, which is derived from chemical synthesis with its action targeting the hepatitis C virus (HCV). It operates primarily as a protease inhibitor, specifically targeting the NS3/4A protease, an essential enzyme for HCV replication. By inhibiting this protease, Paritaprevir effectively disrupts the viral life cycle, preventing the virus from maturing and proliferating within the host cells.</p>Purity:Min. 95%SE 563
CAS:<p>SE 563 is a biocontrol agent, which is an organism-based product derived from natural sources. It is sourced from a specific strain of entomopathogenic nematodes known for their effectiveness in targeting and controlling insect pests. The mode of action involves the nematodes seeking out their insect hosts in the soil, entering through natural openings, and releasing symbiotic bacteria that kill the host from within.</p>Formula:C22H17ClF3NO3Purity:Min. 95%Molecular weight:435.08491Maribavir
CAS:<p>Potent antiviral against HCMV and Epstein-Barr virus (EBV)</p>Formula:C15H19Cl2N3O4Purity:Min. 95%Molecular weight:376.24 g/molBalapiravir
CAS:<p>Balapiravir is an antiviral agent, which is a synthetic derivative based on natural compounds, specifically designed to inhibit the replication of various viral pathogens. The source of Balapiravir integrates bio-based elements with modifications to enhance its therapeutic efficacy.</p>Formula:C21H30N6O8Purity:Min. 95%Molecular weight:494.5 g/molIndinavir monohydrate
CAS:<p>Indinavir monohydrate is an antiretroviral medication, which is a synthetic pharmaceutical compound, specifically a protease inhibitor, used in the treatment of HIV infection. It is derived from chemical synthesis processes that follow rigorous standards to produce a pharmacologically active compound. Indinavir functions by selectively inhibiting the HIV-1 protease enzyme, which is crucial for the viral replication cycle. By binding to the active site of the enzyme, indinavir prevents the cleavage of viral polypeptides, leading to the production of immature and non-infectious viral particles.</p>Purity:Min. 95%Faldaprevir
CAS:<p>Hepatitis C virus protease inhibitor</p>Formula:C40H49BrN6O9SPurity:Min. 95%Color and Shape:White PowderMolecular weight:869.82 g/molZiresovir
CAS:<p>Respiratory syncytial virus (RSV) fusion (F) protein inhibitor</p>Formula:C22H25N5O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:439.53 g/molSofosbuvir - Bio-X ™
CAS:<p>Sofosbuvir is an antiviral agent that is used for the treatment of hepatitis C infections and is used in combination with other antiviral agents. This drug is an inhibitor of viral RNA polymerase called non-structural protein 5B (NS5B). As a result, it inhibits viral RNA replication.</p>Formula:C22H29FN3O9PPurity:Min. 95%Color and Shape:PowderMolecular weight:529.45 g/molVicriviroc
CAS:<p>Vicriviroc is an investigational pharmaceutical compound, specifically classified as an HIV entry inhibitor. It originates from a synthetic source, designed to target the CCR5 co-receptor on human immune cells. The mode of action involves blocking this co-receptor, thereby preventing the HIV virus from binding and fusing with the host cell membrane. This inhibition effectively obstructs the virus's ability to enter and infect the host cells, particularly those within the chemokine receptor family.</p>Formula:C28H38F3N5O2Purity:Min. 95%Molecular weight:533.63 g/molLobucavir
CAS:<p>Lobucavir is an antiviral compound with a mode of action that inhibits viral DNA polymerase. It is used for treating infections caused by herpesviruses and hepatitis B virus.</p>Formula:C11H15N5O3Purity:Min. 95%Molecular weight:265.27 g/molUC-781
CAS:<p>UC-781, a potent NNRTI, inhibits HIV-1 with a C50 of 5 nM and is stable across pH and temperatures.</p>Formula:C17H18ClNO2SPurity:92.17%Color and Shape:SolidMolecular weight:335.85Tenofovir exalidex
CAS:<p>Tenofovir exalidex (CMX 157) is a lipid-conjugated acyclic nucleotide analog of Tenofovir, demonstrating efficacy against wild-type and antiretroviral-resistant</p>Formula:C28H52N5O5PPurity:99.83%Color and Shape:SolidMolecular weight:569.72HDAC3-IN-T247
CAS:<p>HDAC3-IN-T247 (HDAC3 inhibitor T247) is a histone deacetylase 3 (HDAC3) inhibitor with antiviral activity that inhibits the proliferation of cancer cells.</p>Formula:C21H19N5OSPurity:98.11% - 98.94%Color and Shape:SolidMolecular weight:389.47AMC-01
CAS:<p>AMC-01 has potential antiviral activity and induces dose- and time-dependent inactivation of eIF2-α via phosphorylation of serine residue 51.</p>Formula:C27H27BrN2O6Purity:99.95%Color and Shape:SolidMolecular weight:555.42BET-BAY 002
CAS:<p>BET-BAY 002 is an effective BET bromodomain inhibitor demonstrating efficacy in vivo and in vitro against multiple myeloma and leukaemia models.</p>Formula:C22H18ClN5OColor and Shape:SolidMolecular weight:403.86IND24
CAS:<p>IND24 has anti-prion activity and can be used to study neurodegenerative diseases.</p>Formula:C21H17N3SPurity:99.64%Color and Shape:SolidMolecular weight:343.44(R,1R)-Tenofovir amibufenamide
CAS:<p>(R,1R)-Tenofovir amibufenamide ((R,1R)-HS-10234) can be used as a Tenofovir prodrug, which can be taken orally and has antiviral activity.</p>Formula:C22H31N6O5PPurity:98.79% - 99.02%Color and Shape:SolidMolecular weight:490.49SARS-CoV-2 nsp13-IN-1
CAS:<p>SARS-CoV-2 nsp13-IN-1 (C1) inhibits nsp13 ssDNA+ATPase (IC50: 6 μM), not ssDNA-ATPase; useful for COVID-19 research.</p>Formula:C27H20N4O2Purity:99.44%Color and Shape:SolidMolecular weight:432.47
